[English] 日本語
Yorodumi
- PDB-6bft: Structure of Bevacizumab Fab mutant in complex with VEGF -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 6bft
TitleStructure of Bevacizumab Fab mutant in complex with VEGF
Components
  • Avastin Heavy Chain Fab fragment mutant
  • Avastin Light Chain Fab fragment mutant
  • Vascular endothelial growth factor A
KeywordsIMMUNE SYSTEM / Avastin / antibody
Function / homology
Function and homology information


basophil chemotaxis / positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway / VEGF-A complex / Signaling by VEGF / cellular stress response to acid chemical / positive regulation of lymphangiogenesis / vascular endothelial growth factor receptor 1 binding / negative regulation of establishment of endothelial barrier / vascular endothelial growth factor receptor binding / VEGF ligand-receptor interactions ...basophil chemotaxis / positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway / VEGF-A complex / Signaling by VEGF / cellular stress response to acid chemical / positive regulation of lymphangiogenesis / vascular endothelial growth factor receptor 1 binding / negative regulation of establishment of endothelial barrier / vascular endothelial growth factor receptor binding / VEGF ligand-receptor interactions / post-embryonic camera-type eye development / positive regulation of mast cell chemotaxis / lymph vessel morphogenesis / primitive erythrocyte differentiation / negative regulation of adherens junction organization / negative regulation of blood-brain barrier permeability / positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway / regulation of nitric oxide mediated signal transduction / VEGF-activated neuropilin signaling pathway / bone trabecula formation / coronary vein morphogenesis / cardiac vascular smooth muscle cell development / lymphangiogenesis / vascular endothelial growth factor receptor-2 signaling pathway / positive regulation of epithelial tube formation / VEGF binds to VEGFR leading to receptor dimerization / motor neuron migration / positive regulation of trophoblast cell migration / positive regulation of axon extension involved in axon guidance / lung vasculature development / vascular wound healing / eye photoreceptor cell development / regulation of hematopoietic progenitor cell differentiation / positive regulation of protein localization to early endosome / endothelial cell chemotaxis / camera-type eye morphogenesis / positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis / positive regulation of protein autophosphorylation / neuropilin binding / positive regulation of branching involved in ureteric bud morphogenesis / induction of positive chemotaxis / coronary artery morphogenesis / transmembrane receptor protein tyrosine kinase activator activity / negative regulation of cell-cell adhesion mediated by cadherin / vascular endothelial growth factor receptor 2 binding / commissural neuron axon guidance / positive regulation of vascular permeability / dopaminergic neuron differentiation / tube formation / positive regulation of vascular endothelial growth factor signaling pathway / positive regulation of blood vessel branching / surfactant homeostasis / platelet-derived growth factor receptor binding / sprouting angiogenesis / retinal ganglion cell axon guidance / cell migration involved in sprouting angiogenesis / extracellular matrix binding / epithelial cell maturation / endothelial cell proliferation / positive regulation of positive chemotaxis / positive regulation of leukocyte migration / cardiac muscle cell development / positive regulation of endothelial cell chemotaxis / Regulation of gene expression by Hypoxia-inducible Factor / positive regulation of cell migration involved in sprouting angiogenesis / vascular endothelial growth factor signaling pathway / artery morphogenesis / positive regulation of peptidyl-tyrosine phosphorylation / positive regulation of DNA biosynthetic process / negative regulation of epithelial to mesenchymal transition / immunoglobulin complex / branching involved in blood vessel morphogenesis / positive regulation of neuroblast proliferation / positive chemotaxis / negative regulation of fat cell differentiation / positive regulation of sprouting angiogenesis / chemoattractant activity / mesoderm development / outflow tract morphogenesis / fibronectin binding / monocyte differentiation / positive regulation of cell division / positive regulation of receptor internalization / macrophage differentiation / mammary gland alveolus development / cellular response to vascular endothelial growth factor stimulus / positive regulation of blood vessel endothelial cell migration / neuroblast proliferation / positive regulation of focal adhesion assembly / vascular endothelial growth factor receptor signaling pathway / positive regulation of osteoblast differentiation / vasculogenesis / heart morphogenesis / ovarian follicle development / cell maturation / lactation / positive regulation of endothelial cell proliferation / TFAP2 (AP-2) family regulates transcription of growth factors and their receptors / epithelial cell differentiation / extracellular matrix
Similarity search - Function
Vascular endothelial growth factor, heparin-binding domain / Vascular endothelial growth factor, heparin-binding domain superfamily / VEGF heparin-binding domain / : / PDGF/VEGF domain / Platelet-derived growth factor, conserved site / PDGF/VEGF domain / Platelet-derived growth factor (PDGF) family signature. / Platelet-derived growth factor (PDGF) family profile. / Platelet-derived and vascular endothelial growth factors (PDGF, VEGF) family ...Vascular endothelial growth factor, heparin-binding domain / Vascular endothelial growth factor, heparin-binding domain superfamily / VEGF heparin-binding domain / : / PDGF/VEGF domain / Platelet-derived growth factor, conserved site / PDGF/VEGF domain / Platelet-derived growth factor (PDGF) family signature. / Platelet-derived growth factor (PDGF) family profile. / Platelet-derived and vascular endothelial growth factors (PDGF, VEGF) family / Cystine Knot Cytokines, subunit B / Cystine-knot cytokines / Cystine-knot cytokine / : / : / Immunoglobulin V-Type / Immunoglobulin V-set domain / Ribbon / Immunoglobulin V-set domain / Immunoglobulin/major histocompatibility complex, conserved site / Immunoglobulins and major histocompatibility complex proteins signature. / Immunoglobulin subtype / Immunoglobulin / Immunoglobulin C-Type / Immunoglobulin C1-set / Immunoglobulin C1-set domain / Ig-like domain profile. / Immunoglobulin-like domain / Immunoglobulin-like domain superfamily / Immunoglobulin-like fold / Immunoglobulins / Immunoglobulin-like / Sandwich / Mainly Beta
Similarity search - Domain/homology
Immunoglobulin gamma-1 heavy chain / Vascular endothelial growth factor A, long form / Ig-like domain-containing protein
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.55 Å
AuthorsChristie, M. / Christ, D.
Funding support Australia, 2items
OrganizationGrant numberCountry
Australian Research Council (ARC)DE160100608 Australia
Australian Research Council (ARC)DP160104915 Australia
CitationJournal: To Be Published
Title: Stable human IgG antibody therapeutics with native framework structure
Authors: Christie, M. / Rouet, R. / Nevoltris, D. / Langley, D. / Schofield, P. / Fabri, L. / Tingey, K. / Lowe, D. / Jermutus, L. / Christ, D.
History
DepositionOct 27, 2017Deposition site: RCSB / Processing site: RCSB
Revision 1.0Oct 31, 2018Provider: repository / Type: Initial release
Revision 1.1Jan 1, 2020Group: Author supporting evidence / Category: pdbx_audit_support / Item: _pdbx_audit_support.funding_organization
Revision 1.2Oct 4, 2023Group: Data collection / Database references / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession
Revision 1.3Nov 15, 2023Group: Data collection / Category: chem_comp_atom / chem_comp_bond / Item: _chem_comp_atom.atom_id / _chem_comp_bond.atom_id_2
Revision 1.4Oct 16, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
B: Avastin Light Chain Fab fragment mutant
A: Avastin Heavy Chain Fab fragment mutant
L: Avastin Light Chain Fab fragment mutant
H: Avastin Heavy Chain Fab fragment mutant
G: Vascular endothelial growth factor A
C: Vascular endothelial growth factor A
hetero molecules


Theoretical massNumber of molelcules
Total (without water)121,34310
Polymers120,7616
Non-polymers5834
Water2,360131
1


  • Idetical with deposited unit
  • defined by author&software
  • Evidence: gel filtration
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area14220 Å2
ΔGint-101 kcal/mol
Surface area47580 Å2
MethodPISA
Unit cell
Length a, b, c (Å)83.279, 88.749, 106.676
Angle α, β, γ (deg.)90.00, 111.87, 90.00
Int Tables number4
Space group name H-MP1211

-
Components

-
Protein , 1 types, 2 molecules GC

#3: Protein Vascular endothelial growth factor A / VEGF-A / Vascular permeability factor / VPF


Mass: 11933.665 Da / Num. of mol.: 2 / Fragment: UNP residues 214-315
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: VEGFA, VEGF / Production host: Escherichia coli (E. coli) / References: UniProt: P15692

-
Antibody , 2 types, 4 molecules BLAH

#1: Antibody Avastin Light Chain Fab fragment mutant


Mass: 23527.969 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human) / References: UniProt: Q8TCD0
#2: Antibody Avastin Heavy Chain Fab fragment mutant


Mass: 24918.730 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human) / References: UniProt: P0DOX5

-
Non-polymers , 3 types, 135 molecules

#4: Chemical ChemComp-SO4 / SULFATE ION


Mass: 96.063 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: SO4
#5: Chemical ChemComp-MES / 2-(N-MORPHOLINO)-ETHANESULFONIC ACID


Mass: 195.237 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: C6H13NO4S / Comment: pH buffer*YM
#6: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 131 / Source method: isolated from a natural source / Formula: H2O

-
Details

Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 3.03 Å3/Da / Density % sol: 59.4 %
Crystal growTemperature: 293 K / Method: vapor diffusion
Details: 100 mM MES, 6.0, 225 mM ammonium sulfate, 13% PEG4000, 10% isopropanol

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: Australian Synchrotron / Beamline: MX2 / Wavelength: 0.9537 Å
DetectorType: ADSC QUANTUM 315r / Detector: CCD / Date: Mar 13, 2015
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.9537 Å / Relative weight: 1
ReflectionResolution: 2.55→45 Å / Num. obs: 47223 / % possible obs: 99.8 % / Redundancy: 5.2 % / Rpim(I) all: 0.056 / Net I/σ(I): 11.6
Reflection shellResolution: 2.55→2.64 Å / Num. unique all: 4516 / CC1/2: 0.816

-
Processing

Software
NameVersionClassification
PHENIX(1.10.1_2155: ???)refinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: PDB entry 1BJ1

1bj1


Resolution: 2.55→45 Å / SU ML: 0.31 / Cross valid method: FREE R-VALUE / σ(F): 0.04 / Phase error: 23.56
RfactorNum. reflection% reflection
Rfree0.2199 2395 5.09 %
Rwork0.1702 --
obs0.1727 47199 99.8 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å
Refinement stepCycle: LAST / Resolution: 2.55→45 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms8194 0 34 131 8359
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.018449
X-RAY DIFFRACTIONf_angle_d1.08211498
X-RAY DIFFRACTIONf_dihedral_angle_d15.3155033
X-RAY DIFFRACTIONf_chiral_restr0.0591251
X-RAY DIFFRACTIONf_plane_restr0.0061471
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
2.5481-2.57710.381410.29442744X-RAY DIFFRACTION95
2.5771-2.60740.33921370.26822987X-RAY DIFFRACTION100
2.6074-2.63920.3151680.25712902X-RAY DIFFRACTION100
2.6392-2.67260.3531530.2492919X-RAY DIFFRACTION100
2.6726-2.70770.29662020.24312896X-RAY DIFFRACTION100
2.7077-2.74480.29711930.21742875X-RAY DIFFRACTION100
2.7448-2.7840.29411770.22112965X-RAY DIFFRACTION100
2.784-2.82560.27291390.22092926X-RAY DIFFRACTION100
2.8256-2.86970.32931500.21752927X-RAY DIFFRACTION100
2.8697-2.91680.26651750.21312885X-RAY DIFFRACTION100
2.9168-2.9670.28761440.21863033X-RAY DIFFRACTION100
2.967-3.0210.28531400.21292847X-RAY DIFFRACTION100
3.021-3.07910.27351400.21312983X-RAY DIFFRACTION100
3.0791-3.14190.23891680.20652882X-RAY DIFFRACTION100
3.1419-3.21020.28511560.20262966X-RAY DIFFRACTION100
3.2102-3.28490.25721210.20472988X-RAY DIFFRACTION100
3.2849-3.3670.25391810.19162894X-RAY DIFFRACTION100
3.367-3.4580.22241450.17782929X-RAY DIFFRACTION100
3.458-3.55970.22591670.172926X-RAY DIFFRACTION100
3.5597-3.67460.23541110.16652970X-RAY DIFFRACTION100
3.6746-3.80580.18861540.15382925X-RAY DIFFRACTION100
3.8058-3.95810.16891770.13992906X-RAY DIFFRACTION100
3.9581-4.13810.16211640.12982908X-RAY DIFFRACTION100
4.1381-4.35610.17421960.11632925X-RAY DIFFRACTION100
4.3561-4.62880.13831470.10952951X-RAY DIFFRACTION100
4.6288-4.98580.1351720.10452879X-RAY DIFFRACTION100
4.9858-5.48670.17151510.12082936X-RAY DIFFRACTION100
5.4867-6.27890.17571240.14962983X-RAY DIFFRACTION100
6.2789-7.90370.20391790.16022882X-RAY DIFFRACTION100
7.9037-45.00890.17491300.15392963X-RAY DIFFRACTION99
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
10.4761-0.0741-0.02650.4125-0.08260.50060.003-0.02450.03720.05330.0722-0.0811-0.07970.05350.00020.21030.0655-0.01180.2399-0.02950.15849.079612.8374164.3931
20.49220.0707-0.03650.240.24940.83920.06290.1141-0.11460.0576-0.02180.06390.095-0.0051-0.00020.1870.01970.00760.2103-0.00820.19756.1157-0.539151.9619
30.47990.15230.10310.50640.16610.5211-0.09640.069-0.0009-0.09420.0003-0.005-0.0046-0.1042-0.05280.1544-0.0050.01170.0654-0.0220.1217-96.4866-19.552997.1873
40.76140.35810.14630.40830.3750.4148-0.0231-0.09830.02940.0589-0.0309-0.01530.08430.041-0.00310.1879-0.00130.00040.10430.02060.1443-92.9318-17.2442115.9105
50.3706-0.1680.18750.2514-0.31680.3933-0.1202-0.39230.11560.04930.0003-0.02450.0326-0.0107-0.00550.20230.0498-0.01210.2817-0.08450.2647-41.56024.3919135.6483
60.1545-0.13120.08170.4129-0.19840.12010.03820.26870.1543-0.0332-0.08540.00070.12260.1673-0.00150.1880.01460.00550.2327-0.02140.2104-46.1438-2.5353121.6357
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection details
1X-RAY DIFFRACTION1(chain 'B' and resid 1 through 214)
2X-RAY DIFFRACTION2(chain 'A' and resid 1 through 230)
3X-RAY DIFFRACTION3(chain 'L' and resid 1 through 213)
4X-RAY DIFFRACTION4(chain 'H' and resid 1 through 223)
5X-RAY DIFFRACTION5(chain 'G' and resid 13 through 107)
6X-RAY DIFFRACTION6(chain 'C' and resid 14 through 107)

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more